Erythropoietic response induced by recombinant human erythropoietin in anemic cancer patients candidate to major abdominal surgery

Hepato-Gastroenterology

Volumn 44, Issue 15, 1997, Pages 685-690

  Braga, M ^a,b   Gianotti, L ^a   Gentilini, O ^a   Vignali, A ^a   Di Carlo, V ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Anemia; Blood transfusion; Cancer; Cost benefit analysis; Erythropoiesis; Erythropoietin; Surgery

Indexed keywords

ANTIANEMIC AGENT; ERYTHROPOIETIN; FERRITIN; HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROCYTE COUNT; ERYTHROPOIESIS; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; IRON BLOOD LEVEL; MALE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE COUNT; STOMACH CANCER; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; AGED; ANEMIA; BLOOD TRANSFUSION; COST-BENEFIT ANALYSIS; ERYTHROCYTE COUNT; ERYTHROPOIESIS; ERYTHROPOIETIN; ERYTHROPOIETIN, RECOMBINANT; FEMALE; FERRITINS; GASTROINTESTINAL NEOPLASMS; HEMATOCRIT; HUMANS; IRON; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROSPECTIVE STUDIES;

EID: 0030960205     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Vignali A, Braga M, Dionigi P, et al. Impact of a programme of autologous blood donation on the incidence of infection in patients with colorectal cancer. Eur J Surg 1995; 161:487-92.
2. Mezrow CK, Bergstein I, Tartter PI. Postoperative infections following autologous and homologous blood transfusions; Transfusion 1992; 32:27-30.
3. Murphy P, Heal JM, Blumberg N. Infection or suspected infection after hip replacement surgery with autologous or homologous blood transfusions. Transfusion 1991; 31:212-7.
4. Gebbia V, Russo R, Gebbia N, et al. Recombinant human erythropoietin accelerates recovery from cisplatin induced anemia in cancer patients: preliminary results. Cancer J 1991; 4:343-7.
5. Goodnough LT, Price TH, Rudnick S, et al. Preoperative red cell production in patients undergoing aggressive autologous blood phlebotomy with and without erythropoietin therapy. Transfusion 1992; 32:441-5.
6. Goodnough LT, Price TH, Friedman KD, et al. A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacy. Transfusion 1994; 34:66-71.
7. Mercuriali F, Zanella A, Barosi G, et al. Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients. Transfusion 1993; 33:55-60.
8. Spivak JL. Recombinant human erythropoietin and its role in transfused medicine. Transfusion 1994; 91; 34:1-4.
9. Watanabe Y, Fuse K, Konishi T, et al. Autologous blood transfusion with recombinant human erythropoietin in heart operations. Ann Thorac Surg. 1991; 51: 767-72.
10. Maeda H, Hitomi Y, Hirata R, et al. Erythropoietin and autologous blood donation. Lancet 1989; 334: 284.
11. Braga M, Gianotti L, Vignali A et al. Evaluation of recombinant human erythropoietin to facilitate autologous blood donation before surgery in anaemic patients with cancer of the gastrointestinal tract. Br J Surg 1995, 82, 1637-1640.
12. Mercuriali F, Gualtieri G, Sinigaglia L et al. Use of recombinant human erythropoietin to assist autologous blood donation by anemic rheumatoid arthritis patients undergoing major orthopedic surgery. Transfusion 1994; 34, 501-6.
13. Miller CB, Jones RJ, Piantadosi S, et al. Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med 1990; 322:1689-92.
14. Vreugdenhil G, Swaak AJG. Aneamia in rheumatoid arthritis: pathogenesis, diagnosis and treatment. Rheumatology 1990; 9:243-8.
15. Means RT, Krantz SB. Progress in understanding the pathogenesis of the anemia of the chronic disease. Blood 1992; 80:1639-42
16. Erslev AJ. Erythropoietin. N Engl J Med 1991; 325:1339-44.
17. Sherwood JB, Goldwasser E, Chilcote R, et al. Sickle cell anemia patients have low erythropoietin levels for their degree of anemia. Blood 1986; 67:46-51.
18. Spivak JL, Barnes DC, Fuchs E, Quinn TC. Serum immunoreactive erythropoietin in HIV infected patients. JAMA 1989; 261:3104-7.
19. Fischl M, Galpin JE, Levine JD et al. Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med 1990; 322:1488-93.
20. Erslev AJ, Wilson J, Caro J. Erythropoietin titers in anemic, nonuremic patients. J Lab Clin Med 1987; 109:429-33.
21. Takashima N, Kondo H, Kahiwazaka S. Suppressed serum erythropoietin response to anemia and the efficacy of the recombinant human erythropoietin in the anemia of the rheumatoid arthritis. J Rheumatol 1990; 17:885-7.
22. Gaudiani VA, Mason HDW. Preoperative erythropoietin in Jehovah's Witnesses who require cardiac procedures. Ann Thorac Surg 1991; 51:823-4.
23. Braga M, Vignali A, Radaelli G, Gianotti L, Di Carlo V. Association between perioperative blood transfusion and postoperative infection in patients having elective operations for gastrointestinal cancer. Eur J Sur 1992; 158:531-6.
24. Tartter PI, Quintero S, Barron DM. Perioperative blood transfusion associated with infectious complications after colo-rectal cancer operations. Am J Surg 1986; 152:479-82.
25. Brunson ME, Alexander JW. Mechanisms of transfusion-induced immunosuppression. Transfusion 1990; 30:651-8.
26. Blumberg N, Heal JM. Transfusion and recipient immune function. Arch Pathol Lab Med 1989; 113: 245-6
27. Vamvakas EC, Moore SB. Blood transfusion and post-operative septic complications. Transfusion 1994; 34:714-27.
28. Mercuriali F, Inghilleri G, Biffi E, Colotti MT, Vinci A, Sinigalia L, Gualtieri G. Comparison between intravenous and subcutaneous recombinant human erythropoietin alpha adminstration for presurgical autologous blood donation in anemic rheumatoid arthritis patients undergoing major orthopedic surgery. Vox Sang (in press).